SkinBioTherapeutics plc (LON:SBTX – Get Free Report)’s share price rose 4.2% during mid-day trading on Thursday . The company traded as high as GBX 12.50 ($0.16) and last traded at GBX 12.38 ($0.16). Approximately 497,913 shares were traded during trading, a decline of 37% from the average daily volume of 791,494 shares. The stock had previously closed at GBX 11.88 ($0.16).
SkinBioTherapeutics Trading Up 4.2 %
The firm’s 50-day simple moving average is GBX 11.77 and its 200 day simple moving average is GBX 10.23. The stock has a market cap of £27.98 million, a P/E ratio of -618.75 and a beta of 2.01. The company has a current ratio of 6.57, a quick ratio of 10.01 and a debt-to-equity ratio of 2.66.
About SkinBioTherapeutics
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.
Read More
- Five stocks we like better than SkinBioTherapeutics
- Why is the Ex-Dividend Date Significant to Investors?
- 3 Leveraged ETFs to Multiply Returns
- Stock Sentiment Analysis: How it Works
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- Why Are Stock Sectors Important to Successful Investing?
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for SkinBioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkinBioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
